{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:55:57Z","timestamp":1794333357299,"version":"4.9.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04253-x","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T10:24:59Z","timestamp":1748514299000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Case report of Lafora disease: a rare genetic disorder manifesting as progressive myoclonic epilepsy"],"prefix":"10.1186","volume":"25","author":[{"given":"Ramtin","family":"Naderian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzane","family":"Vafaeian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyed Mohamad","family":"Hoseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Sanami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"4253_CR1","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/practneurol-2014-000994","volume":"15 3","author":"N Malek","year":"2015","unstructured":"Malek N, Stewart W, Greene J. The progressive myoclonic epilepsies. Pract Neurol. 2015;15(3):164\u201371.","journal-title":"Pract Neurol"},{"key":"4253_CR2","doi-asserted-by":"publisher","first-page":"106839","DOI":"10.1016\/j.yebeh.2019.106839","volume":"103","author":"MS Gentry","year":"2020","unstructured":"Gentry MS, Afawi Z, Armstrong DD, Delgado-Escueta A, Goldberg YP, Grossman TR, et al. The 5th international Lafora epilepsy workshop: basic science elucidating therapeutic options and Preparing for therapies in the clinic. Epilepsy Behav. 2020;103:106839. https:\/\/doi.org\/10.1016\/j.yebeh.2019.106839.","journal-title":"Epilepsy Behav"},{"key":"4253_CR3","doi-asserted-by":"publisher","DOI":"10.1684\/epd.2016.0842","author":"J Turnbull","year":"2016","unstructured":"Turnbull J, Tiberia E, Striano P, Genton P, Carpenter S, Ackerley CA, et al. Lafora disease. Epileptic Disord. 2016;18(s2):S38-S62. https:\/\/doi.org\/10.1684\/epd.2016.0842.","journal-title":"Epileptic Disord"},{"key":"4253_CR4","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1212\/01.WNL.0000096017.19978.CB","volume":"61 11","author":"DM Andrade","year":"2003","unstructured":"Andrade DM, Ackerley CA, Minett TSC, Teive HAG, Bohlega S, Scherer SW, et al. Skin biopsy in Lafora disease: genotype\u2013phenotype correlations and diagnostic pitfalls. Neurology. 2003;61(11):1611\u20134.","journal-title":"Neurology"},{"key":"4253_CR5","first-page":"81","volume":"9 2","author":"F Barbieri","year":"1987","unstructured":"Barbieri F, Santangelo R, Gasparo-Rippa P, Santoro M. Biopsy findings (cerebral cortex, muscle, skin) in Lafora disease. Acta Neurol. 1987;9(2):81\u201394.","journal-title":"Acta Neurol"},{"key":"4253_CR6","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1212\/WNL.20.2.160","volume":"20 2","author":"M Sakai","year":"1970","unstructured":"Sakai M, Austin J, Witmer F, Trueb L. Studies in myoclonus epilepsy (Lafora body form): II. Polyglucosans in the systemic deposits of myoclonus epilepsy and in corpora amylacea. Neurology. 1970;20(2):160.","journal-title":"Neurology"},{"key":"4253_CR7","first-page":"311","volume":"32 4","author":"M Shirozu","year":"1986","unstructured":"Shirozu M, Hashimoto M, Tomimatsu M, Nakazawa Y, Anraku S, Nagata M. Lafora disease diagnosed by skin biopsy. Kurume Med J. 1986;32(4):311\u20133.","journal-title":"Kurume Med J"},{"key":"4253_CR8","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1212\/WNL.31.12.1564","volume":"31 12","author":"S Carpenter","year":"1981","unstructured":"Carpenter S, Karpati G. Sweat gland duct cells in Lafora disease: diagnosis by skin biopsy. Neurology. 1981;31(12):1564.","journal-title":"Neurology"},{"issue":"2","key":"4253_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ncpneuro0706","volume":"4","author":"P Striano","year":"2008","unstructured":"Striano P, Zara F, Turnbull J, Girard J-M, Ackerley CA, Cervasio M, et al. Typical progression of myoclonic epilepsy of the Lafora type: a case report. Nat Clin Pract Neurol. 2008;4(2):106\u201311.","journal-title":"Nat Clin Pract Neurol"},{"key":"4253_CR10","doi-asserted-by":"publisher","first-page":"1202971","DOI":"10.3389\/fneur.2023.1202971","volume":"14","author":"G d\u2019Orsi","year":"2023","unstructured":"d\u2019Orsi G, Farolfi A, Muccioli L, Palumbo O, Palumbo P, Modoni S, et al. Association of CSF and PET markers of neurodegeneration with electroclinical progression in Lafora disease. Front Neurol. 2023;14:1202971.","journal-title":"Front Neurol"},{"key":"4253_CR11","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1111\/j.1528-1157.1993.tb02588.x","volume":"34","author":"JN Acharya","year":"1993","unstructured":"Acharya JN, Satishchandra P, Asha T, Shankar SK. Lafora\u2019s disease in South India: a clinical, electrophysiologic, and pathologic study. Epilepsia. 1993;34(3):476\u201387.","journal-title":"Epilepsia"},{"key":"4253_CR12","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1528-1157.1991.tb05548.x","volume":"32 6","author":"C Yen","year":"1991","unstructured":"Yen C, Beydoun A, Drury I. Longitudinal EEG studies in a kindred with Lafora disease. Epilepsia. 1991;32(6):895\u20139.","journal-title":"Epilepsia"},{"key":"4253_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41439-018-0015-9","volume":"5 1","author":"N Araya","year":"2018","unstructured":"Araya N, Takahashi Y, Shimono M, Fukuda T, Kato M, Nakashima M, et al. A recurrent homozygous NHLRC1 variant in siblings with Lafora disease. Hum Genome Variation. 2018;5(1):16.","journal-title":"Hum Genome Variation"},{"key":"4253_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ajhg.2023.11.009","volume":"111 1","author":"LG Biesecker","year":"2024","unstructured":"Biesecker LG, Byrne AB, Harrison SM, Pesaran T, Sch\u00e4ffer AA, Shirts BH, et al. ClinGen guidance for use of the PP1\/BS4 co-segregation and PP4 phenotype specificity criteria for sequence variant pathogenicity classification. Am J Hum Genet. 2024;111(1):24\u201338.","journal-title":"Am J Hum Genet"},{"key":"4253_CR15","first-page":"494","volume":"39 5","author":"Y Guo","year":"2022","unstructured":"Guo Y, Wang L, Xu Z, Bai Y, Wang W, Wu H, et al. Analysis of phenotype and FH gene variation in a pedigree affected with hereditary leiomyomatosis and renal cell carcinoma syndrome. Zhonghua Yi Xue Yi Chuan Xue Za zhi\u2009=\u2009zhonghua Yixue Yichuanxue zazhi\u2009=\u2009chinese. J Med Genet. 2022;39(5):494\u20138.","journal-title":"J Med Genet"},{"issue":"1","key":"4253_CR16","first-page":"34","volume":"18","author":"\u00d6 Bekta\u015f","year":"2013","unstructured":"Bekta\u015f \u00d6, Y\u0131lmaz A, Okcu AH, Teber S, Aksoy E, Deda G. A type of progressive myoclonic epilepsy, Lafora disease: A case report. Eastern J Med. 2013;18(1):34\u20136.","journal-title":"Eastern J Med"},{"key":"4253_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-023-02880-6","volume":"18","author":"F Pondrelli","year":"2023","unstructured":"Pondrelli F, Minardi R, Muccioli L, Zenesini C, Vignatelli L, Licchetta L, et al. Prognostic value of pathogenic variants in Lafora disease: systematic review and meta-analysis of patient-level data. Orphanet J Rare Dis. 2023;18(1):263.","journal-title":"Orphanet J Rare Dis"},{"key":"4253_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-021-01989-w","volume":"16","author":"F Pondrelli","year":"2021","unstructured":"Pondrelli F, Muccioli L, Licchetta L, Mostacci B, Zenesini C, Tinuper P, et al. Natural history of Lafora disease: a prognostic systematic review and individual participant data meta-analysis. Orphanet J Rare Dis. 2021;16:1\u201310.","journal-title":"Orphanet J Rare Dis"},{"key":"4253_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1684\/epd.2017.0892","volume":"19","author":"MA Mikati","year":"2017","unstructured":"Mikati MA, Tabbara F. Managing Lafora body disease with vagal nerve stimulation. Epileptic Disord. 2017;19(1):82\u20136.","journal-title":"Epileptic Disord"},{"key":"4253_CR20","unstructured":"Jansen AC, Andermann E. Progressive myoclonus epilepsy, Lafora type. 2019."},{"key":"4253_CR21","doi-asserted-by":"publisher","DOI":"10.1684\/epd.2016.0841","author":"A Crespel","year":"2016","unstructured":"Crespel A, Ferlazzo E, Franceschetti S, Genton P, Gouider R, K\u00e4lvi\u00e4inen R, et al. Unverricht-Lundborg disease. Epileptic Disord. 2016;18(s2):S28-S37. https:\/\/doi.org\/10.1684\/epd.2016.0841.","journal-title":"Epileptic Disord"},{"key":"4253_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.seizure.2019.08.012","volume":"71","author":"A Orsini","year":"2019","unstructured":"Orsini A, Valetto A, Bertini V, Esposito M, Carli N, Minassian BA, et al. The best evidence for progressive myoclonic epilepsy: A pathway to precision therapy. Seizure. 2019;71:247\u201357. https:\/\/doi.org\/10.1016\/j.seizure.2019.08.012.","journal-title":"Seizure"},{"key":"4253_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/genes15020171","volume":"15 2","author":"V Zimmern","year":"2024","unstructured":"Zimmern V, Minassian B. Progressive myoclonus epilepsy: A scoping review of diagnostic, phenotypic and therapeutic advances. Genes. 2024;15(2):171.","journal-title":"Genes"},{"issue":"5","key":"4253_CR24","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.bbamcr.2019.02.010","volume":"1866","author":"M Villanueva-Paz","year":"2019","unstructured":"Villanueva-Paz M, Povea-Cabello S, Villal\u00f3n-Garc\u00eda I, Su\u00e1rez-Rivero JM, \u00c1lvarez-C\u00f3rdoba M, de la Mata M, et al. Pathophysiological characterization of MERRF patient-specific induced neurons generated by direct reprogramming. Biochim Et Biophys Acta (BBA)-Molecular Cell Res. 2019;1866(5):861\u201381.","journal-title":"Biochim Et Biophys Acta (BBA)-Molecular Cell Res"},{"key":"4253_CR25","unstructured":"Ibrahim F, Murr NI. Lafora disease. StatPearls [Internet]. StatPearls Publishing; 2024."},{"key":"4253_CR26","doi-asserted-by":"publisher","first-page":"630366","DOI":"10.3389\/fneur.2021.630366","volume":"12","author":"G Assenza","year":"2021","unstructured":"Assenza G, Nocerino C, Tombini M, Di Gennaro G, D\u2019Aniello A, Verrotti A, et al. Perampanel improves cortical myoclonus and disability in progressive myoclonic epilepsies: a case series and a systematic review of the literature. Front Neurol. 2021;12:630366.","journal-title":"Front Neurol"},{"key":"4253_CR27","doi-asserted-by":"publisher","unstructured":"Bisulli F, Muccioli L, d\u2019Orsi G, Canafoglia L, Freri E, Licchetta L, et al. Treatment with Metformin in twelve patients with Lafora disease. Orphanet J Rare Dis. 2019;14(1):149. https:\/\/doi.org\/10.1186\/s13023-019-1132-3.","DOI":"10.1186\/s13023-019-1132-3"},{"key":"4253_CR28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.neurol.2021.06.006","volume":"178 4","author":"S Mitra","year":"2022","unstructured":"Mitra S, Gumusgoz E, Minassian BA. Lafora disease: current biology and therapeutic approaches. Rev Neurol. 2022;178(4):315\u201325.","journal-title":"Rev Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04253-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04253-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04253-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T10:25:02Z","timestamp":1748514302000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04253-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4253"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04253-x","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the participants and\/or their parents\/legal guardians for publication of the case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"230"}}